Related Party Transactions (Details Narrative) - USD ($)						1 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2024	Aug. 15, 2024	Aug. 30, 2023	Aug. 15, 2023	May 03, 2023	Oct. 31, 2023	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Non compensatory options acquire					8,000,000
Shares issued price per share					$ 0.25
Issuance of Series D Preferred Stock to PIPE investors, net of issuance costs							$ 16,447,000
Liquidated damages									$ 500,000
Common stock voting rights thresold percentage		29.90%
Series E PIPE Investor [Member]
Consideration recieved per transaction				$ 20,000,000.0
Number of shares issued				39,614
Warrant issued				8,000,000
Exercise price				$ 6.00
Subordinated Promissory Note and Subordinated Note Warrants [Member]
Debt instrument, issued, principal amount	$ 5,000,000.0
Debt maturity date	Dec. 31, 2025
Subordinated Promissory Note and Subordinated Note Warrants [Member] | Maximum [Member]
Warrant, total	1,141,552
Series D Preferred Stock [Member]
Issuance of common stock and warrants in conjunction with purchase of Exok Option assets, shares					4,423
Series D Preferred Stock [Member] | Jonathan H Gary [Member]
Issuance of Series D Preferred Stock to PIPE investors, net of issuance costs					$ 750,000
Series D Preferred Stock and D Pipe Warrants [Member] | Jonathan H Gary [Member]
Issuance of Series D Preferred Stock to PIPE investors, net of issuance costs					254,875
Series E Preferred Stock [Member]
Number of shares issued				20,000
Rose Hill Holdings Limited [Member]
Non compensatory options acquire	800,000
Bristol Investment Fund Ltd [Member] | Series D Preferred Stock [Member]
Issuance of Series D Preferred Stock to PIPE investors, net of issuance costs					$ 1,250,000
Noncompensatory Option Purchase Agreement [Member]
Issuance of common stock and warrants in conjunction with purchase of Exok Option assets, shares	800,000		200,000
Shares issued price per share	$ 0.25		$ 0.25
Consent Agreement [Member]
Related party transaction description of transaction		the Company entered into a Consent and Agreement (the “Consent and Agreement”) with the O’Neill Trust, pursuant to which the O’Neill Trust (a) consented to, and waived any and all negative covenants with respect to, any and all transactions the Company may consummate in connection with the funding of the NRO Acquisition and its ongoing operations; (b) released its mortgage on certain property of the Company, which was established in favor of the O’Neill Trust securing the Company’s obligations under the Series E Certificate; and (c) agreed to (i) amend Section 6(d) of the Series E Certificate to increase the Beneficial Ownership Limitation Ceiling from 9.99% to 49.9%, (ii) subject to consent from the requisite holders of the Series D Preferred Stock, amend Section 6(d) of the Series D Certificate to increase the Beneficial Ownership Limitation from 9.99% to 49.9% and (iii) amend Section 2(e) of each of the O’Neill Trust’s Series D A Warrant and Series E A Warrant and Section 2(d) of the O’Neill Trust’s Series E B Warrant to increase the Beneficial Ownership Limitation Ceiling from 25% to 49.9%.
Common stock voting rights thresold percentage		49.90%
AR Debentures [Member]
Stock issued during period, shares, conversion of units						400,666